nVerses Capital »

Silverback Therapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $103k 13k 8.01
2024-09-30 $31k 2.1k 14.50

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Abbvie (ABBV)
Knight-swift Transn Hldgs In Cl A (KNX)
Wal-Mart Stores (WMT)
Target Corporation (TGT)
Peoples Ban (PEBO)
Delta Air Lines Com New (DAL)
Astrana Health Com New (ASTH)
SM Energy (SM)
American Superconductor Corp Shs New (AMSC)
Mirum Pharmaceuticals (MIRM)
Arthur J. Gallagher & Co. (AJG)
Wright Express (WEX)
Mosaic (MOS)
Marriott Vacations Wrldwde Cp (VAC)

View all positions for nVerses Capital

Top funds holding Silverback Therapeutics

RA Capital Management
Rubric Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Tyro Capital Management
Standard Life Aberdeen
Sr One Capital Management
State Street Corporation
Vanguard Capital Management
Millennium Management
Janney Montgomery Scott
UBS Group
Geode Capital Management
Boothbay Fund Management

View all funds holding Silverback Therapeutics